Skye Bioscience

FDA approves Skye Bioscience’s IND for glaucoma therapy trial
Clinical Trials Arena
Wed, 12/21/22 - 11:20 am
Skye Bioscience
clinical trials
SBI-100
glaucoma
Small cannabinoid biotech gets hit with cyberattack, clinical trial delays
Endpoints
Wed, 07/20/22 - 10:23 am
Skye Bioscience
cannabinoids
cyberattacks
glaucoma
clinical trials
cybersecurity